Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
May 29 2024 - 9:00AM
Business Wire
Eurofins CDMO Alphora Inc., a global Contract Development &
Manufacturing Organization and part of the international network of
Eurofins laboratories, is pleased to announce a significant
expansion of its Drug Product Analytical Services Laboratory,
increasing its footprint three-fold. Located in Mississauga,
Canada, the expanded facility marks the addition of specialized
equipment and analytical techniques, tailored to offer
comprehensive analytical support for drug product programs. The
laboratory has expanded to encompass water activity measurements,
intrinsic dissolution studies, additional glove box systems, an
added suite of HPLCs, new stability chambers and gas
chromatography.
Eurofins CDMO Alphora Inc is committed to supporting the
development and manufacturing of life-saving therapies and
providing the highest standards of quality, customized support, and
expert analysis to its clients. Through the Drug Product Analytical
Services Laboratory expansion and Eurofins CDMO Alphora Inc’s drug
product capabilities and extensive suite of Solid-State Research
and Development, Eurofins CDMO Alphora is well positioned to
support even the most challenging drug development programs.
To learn more, please visit:
https://www.eurofins.com/biopharma-services/cdmo/services/small-molecules-dp-development-manufacturing/
About Eurofins CDMO Alphora Inc. Eurofins CDMO is a
leading global Contract Development and Manufacturing Organization
that provides clients with active pharmaceutical ingredients
(“API’s”) / drug substance and drug product development for small
molecules, biologics and phytocannabinoids via synthetic route. Its
service offering encompasses drug substance/API development, solid
state research and development, pre-formulation, formulation and
development, analytical development, Non-GMP & GMP
manufacturing, upstream development, downstream development, ADC
Conjugation. Operating with facilities in Europe, North America and
India, Eurofins CDMO is accredited through the FDA, EMA, ANSM,
ANSES, FAMHP, PMDA, and Health Canada.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With ca. 62,000 staff across a
network of more than 900 laboratories in over 1,000 companies in 62
countries, Eurofins offers a portfolio of over 200,000 analytical
methods. Eurofins Scientific S.E. shares are listed on Euronext
Paris Stock Exchange.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240529930942/en/
For further information: Cheryl Young Senior Vice
President Business Operations Eurofins CDMO Alphora Inc.
Cheryl.Young@bpt.eurofinsca.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From May 2024 to Jun 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2023 to Jun 2024